See Spruce Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap

145.68M

Dividend TTM

0.00

P/E TTM

-1.48

EPS TTM

-35.81

Revenue

0.00

Net Profit

-53.04M

ROE

-148.85%

ROA

-84.70%

Spruce Biosciences Inc Earnings Date

Latest Release

Aug 12, 2026

EPS / Forecast

-6.68/-5.80

Revenue / Forecast

--/0.00

Financial Statement Highlights

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

Financial Indicators

EPS

97.45%-6.68

62.69%-8.94

73.50%-11.28

7.37%-14.58

-1467.72%-262.25

-12.95%-23.96

-132.71%-42.58

30.82%-15.75

29.48%-16.73

29.45%-21.22

48.42%-18.30

---22.76

---23.72

---30.07

---35.47

---1.49

----

Revenue

----

-100.00%0.00

-75.86%697.00K

-80.41%602.00K

-25.64%1.61M

1.93%2.00M

--2.89M

--3.07M

--2.17M

--1.96M

----

Net Profit

-685.15%-16.23M

12.64%-12.27M

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

Net Margin

----

-880.73%-3380.06%

-258.28%-1440.37%

3.73%-570.25%

10.84%-580.67%

---344.65%

---402.02%

---592.33%

---651.27%

----

Gross Margin

----

0.00%100.00%

--100.00%

----

Debt to assets ratio

59.53%6.89%

170.81%11.51%

-100.00%0.00%

6.78%3.52%

28.24%4.32%

26.41%4.25%

20.23%3.86%

-0.28%3.30%

2.81%3.37%

3.40%3.36%

-44.02%3.21%

--3.31%

--3.28%

--3.25%

--5.74%

--5.14%

----

Income Statement

Revenue

----

-100.00%0.00

-75.86%697.00K

-80.41%602.00K

-25.64%1.61M

1.93%2.00M

--2.89M

--3.07M

--2.17M

--1.96M

----

Operating profit

-513.37%-16.51M

17.29%-11.99M

53.89%-11.10M

12.53%-8.23M

73.18%-2.69M

-14.72%-14.49M

-115.64%-24.07M

31.12%-9.41M

28.17%-10.04M

4.29%-12.63M

7.81%-11.16M

-18.18%-13.66M

-17.59%-13.97M

-12.49%-13.20M

-32.57%-12.11M

-1.38%-11.56M

-1.43%-11.88M

-19.52%-11.73M

-9.60%-9.13M

-19.26%-11.40M

Net Profit

-685.15%-16.23M

12.64%-12.27M

37.83%-14.65M

5.29%-8.21M

77.49%-2.07M

-20.78%-14.04M

-136.77%-23.56M

29.81%-8.67M

28.41%-9.18M

9.12%-11.63M

10.71%-9.95M

-8.36%-12.35M

-8.02%-12.82M

-8.75%-12.79M

-21.34%-11.14M

0.40%-11.40M

-0.83%-11.87M

-18.96%-11.76M

-10.15%-9.18M

-19.40%-11.45M

Balance Sheet

Current assets

382.77%101.15M

79.98%55.03M

17.88%52.11M

-77.17%14.52M

-71.65%20.95M

-64.39%30.58M

-56.74%44.21M

-42.80%63.57M

-40.46%73.91M

-37.43%85.86M

22.22%102.18M

19.26%111.14M

28.62%124.13M

44.31%137.24M

-9.02%83.61M

-0.78%93.19M

-13.35%96.51M

-37.27%95.10M

-42.71%91.89M

27.61%93.92M

Total current liabilities

36.02%10.96M

-24.78%11.78M

-33.84%10.09M

-20.50%9.43M

-43.58%8.06M

-14.83%15.67M

-37.68%15.25M

-50.98%11.86M

-37.16%14.29M

-20.01%18.39M

96.55%24.46M

101.55%24.19M

125.04%22.73M

156.38%23.00M

40.31%12.45M

32.45%12.00M

44.73%10.10M

30.92%8.97M

-9.14%8.87M

-10.16%9.06M

Total assets

371.37%102.85M

77.47%56.17M

17.28%53.02M

-76.48%15.31M

-71.11%21.82M

-63.85%31.65M

-56.51%45.21M

-42.38%65.10M

-40.05%75.52M

-37.07%87.54M

21.36%103.95M

18.56%112.98M

20.52%125.96M

20.98%139.11M

-32.29%85.65M

-29.45%95.30M

-27.14%104.52M

-25.33%114.99M

-22.35%126.49M

72.12%135.09M

Total liabilities

121.32%19.12M

31.81%21.52M

-35.90%10.51M

-26.27%9.93M

-47.16%8.64M

-21.95%16.32M

-40.27%16.39M

-51.22%13.46M

-44.39%16.35M

-32.79%20.91M

59.87%27.44M

64.08%27.60M

90.99%29.40M

111.03%31.12M

13.54%17.16M

9.47%16.82M

15.38%15.39M

11.13%14.74M

12.33%15.12M

6.12%15.37M

Total equity

535.28%83.73M

126.10%34.65M

47.52%42.52M

-89.57%5.39M

-77.72%13.18M

-77.00%15.32M

-62.33%28.82M

-39.52%51.64M

-38.72%59.17M

-38.31%66.62M

11.71%76.51M

8.80%85.38M

8.35%96.56M

7.74%108.00M

-38.51%68.49M

-34.45%78.47M

-31.50%89.12M

-28.77%100.24M

-25.47%111.37M

87.05%119.72M

Cash Flow Statement

Net operating income

-150.57%-22.12M

31.39%-8.73M

68.78%-6.46M

42.36%-5.32M

20.51%-8.83M

14.92%-12.73M

-84.47%-20.68M

24.83%-9.22M

-657.25%-11.11M

-26.87%-14.96M

4.51%-11.21M

-43.03%-12.27M

120.89%1.99M

0.30%-11.79M

-19.79%-11.74M

-12.91%-8.58M

1.58%-9.54M

-34.59%-11.83M

-5.75%-9.80M

0.00%-7.60M

Net investment

---135.00K

---10.00K

----

-100.00%0.00

-36.17%9.30M

182.83%13.99M

-34.34%22.00M

239.95%10.48M

343.51%14.57M

-36.95%-16.89M

155.08%33.51M

-39326.32%-7.49M

-24829.17%-5.98M

-28586.05%-12.34M

Net financing

16217.50%64.47M

3485.89%13.92M

7251.04%44.69M

0.74%-402.00K

-9.59%-400.00K

-81.06%-411.00K

-13.22%-625.00K

0.00%-405.00K

15.51%-365.00K

-100.45%-227.00K

-1633.33%-552.00K

-350.00%-405.00K

-336.36%-432.00K

57519.32%50.53M

-78.44%36.00K

-629.41%-90.00K

-156.25%-99.00K

-131.10%-88.00K

-99.82%167.00K

-99.96%17.00K

Revenue

By Business

Period:

No Data

By Region

Period:

No Data

FAQs

What are the current assets of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its current assets were 52.11M, with a year-on-year change of 17.88.

What are the total assets of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its total assets of Spruce Biosciences Inc were 53.02M, with a year-on-year change of 17.28.

What are the total liabilities of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its total liabilities of Spruce Biosciences Inc were 10.51M, with a year-on-year change of -35.90.

What is the total equity of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its total equity of Spruce Biosciences Inc was 42.52M, with a year-on-year change of 47.52.

What is the net operating income of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its net operating income of Spruce Biosciences Inc was -36.51M, with a year-on-year change of 34.97.

What is the net financing of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its net financing of Spruce Biosciences Inc was 43.48M, with a year-on-year change of 2780.70.

What is the Earnings Per Share (EPS) of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -50.83, with a year-on-year change of 47.27.

What is the net income of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its net income was -38.97M, with a year-on-year change of 26.53.

What is the Return on Equity (ROE) of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -109.24, with a year-on-year change of -8.48.

What is the Return on Assets (ROA) of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -79.34, with a year-on-year change of -11.56.

What is the operating profit of Spruce Biosciences Inc?



According to Spruce Biosciences Inc's FY2025 earnings report, its operating profit was -36.51M, with a year-on-year change of 34.97.